Cargando…
Safety and Efficacy of Repeat Administration of Triamcinolone Acetonide Extended-release in Osteoarthritis of the Knee: A Phase 3b, Open-label Study
INTRODUCTION: The aim of this work is to assess the safety and efficacy of repeat administration of triamcinolone acetonide extended-release (TA–ER) in patients with symptomatic knee osteoarthritis (OA), including those with advanced radiographic severity. METHODS: In this phase 3b, single-arm, open...
Autores principales: | Spitzer, Andrew I., Richmond, John C., Kraus, Virginia B., Gomoll, Andreas, Jones, Deryk G., Huffman, Kim M., Peterfy, Charles, Cinar, Amy, Lufkin, Joelle, Kelley, Scott D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6393263/ https://www.ncbi.nlm.nih.gov/pubmed/30741382 http://dx.doi.org/10.1007/s40744-019-0140-z |
Ejemplares similares
-
Expanding the Potential of Nonoperative Therapies In Advanced Knee
Osteoarthritis: Treatment Response to Repeat Administration Triamcinolone
Acetonide Extended-Release Is Similar Across Kellgren-Lawrence Grades
2-4
por: Jones, Deryk G., et al.
Publicado: (2019) -
A randomized, phase IIa study to assess the systemic exposure of
triamcinolone acetonide following injection of extended-release triamcinolone
acetonide or traditional triamcinolone acetonide into both knees of patients
with bilateral knee osteoarthritis
por: Kivitz, Alan, et al.
Publicado: (2019) -
Safety and Systemic Exposure of Triamcinolone Acetonide Following Ultrasound-Guided Intra-Articular Injection of Triamcinolone Extended-Release or Standard Triamcinolone Acetonide in Patients with Shoulder Osteoarthritis: An Open-Label, Randomized Study
por: Hanson, Peter, et al.
Publicado: (2021) -
Efficacy of Triamcinolone Acetonide Extended-Release in Participants with Unilateral Knee Osteoarthritis: A Post Hoc Analysis
por: Langworthy, Michael J., et al.
Publicado: (2019) -
A Randomized, Open-Label, Single-Dose Study to Assess Safety and Systemic Exposure of Triamcinolone Acetonide Extended-Release in Patients With Hip Osteoarthritis
por: Kivitz, Alan, et al.
Publicado: (2022)